The Food and Drug Administration says it will offer ultra-fast review to three psychedelic drugs being studied for hard-to-treat mental health conditions, including depression. https://apnews.com/article/psychedelics-trump-fda-kennedy-drugs-mdma-afd00baa39f4300e4631d1f3eed27b7f?taid=69eb9a8ce23f1b000178ca3c&utm_campaign=TrueAnthem&utm_medium=AP&utm_source=Voante